Evidence map›Paper›PMID 39488707›Full record

ArticleMalaria journal2024

Efficacy of PermaNet

Nashon Ogutu, Silas Agumba, Vincent Moshi, Patrick Onyango, Collins Ouma, Edith Ramaita, Lenson Kariuki, John E Gimnig, Bernard Abong'o, Eric Ochomo

Abstract readComparative Study
In one paragraph

Article in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nashon OgutuResearch World Limited Company, Kisumu, Kenya.
Silas AgumbaKenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
Vincent MoshiKenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
Patrick OnyangoDepartment of Zoology, School of Physical and Biological Science, Maseno University, Maseno, Kenya.
Collins OumaDepartment of Biomedical Sciences and Technology, School of Public Health and Community Development, Maseno University, Maseno, Kenya.
Edith RamaitaNational Malaria Control Programme, Ministry of Health, Nairobi, Kenya.
Lenson KariukiNational Malaria Control Programme, Ministry of Health, Nairobi, Kenya.
John E GimnigDivision for Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Bernard Abong'oKenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
Eric OchomoKenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya. ericochomo@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPyrethroid-chlorfenapyr nets have shown significant epidemiological impact over pyrethroid-only and pyrethroid plus piperonyl-butoxide (PBO) in Africa. A non-inferiority evaluation of PermaNet

methodsThis study was an experimental hut trial, following a 7 by 7 Latin Square design. Seven treatments and seven sleepers were deployed in the experimental huts daily and rotated weekly and daily, respectively. Mosquitoes were collected every morning between 06:30 h and 08:30 h and were assessed for blood feeding and then monitored for immediate knockdown 1-h post collection and delayed mortality after 72 h. Differences in proportional outcomes were analysed using the blocked logistic regression model, while differences in numerical outcomes were analysed using the negative binomial regression model. Non-inferiority determination was performed based on World Health Organization (WHO) protocol.

resultsMortality at 72 h was 30.2% for PermaNet 3.0, 44.4% for the Interceptor

conclusionPermaNet

Indexed as

AnophelesInsecticidesInsecticide-Treated BednetsMosquito ControlPyrethrinsAnimalsFemaleHumansInsecticide ResistanceKenyaMalariaMosquito VectorsNitrileschlorfenapyrdecamethrinInsecticidesNitrilesPyrethrinsAnopheles funestusInterceptor® G2KenyaNon-inferiorityPermaNet® 3.0PermaNet® DualPyrethroid-resistance

Identifiers

PMID39488707
PMCPMC11531690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.